Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases is a phase 2, interventional study registered as NCT02185443 by University of Sao Paulo, with a registry enrolment figure of 43 participants, started 2014-05 and due to reach its primary completion in 2026-12. Interventions recorded: SBRT. Conditions listed: Liver Metastases; Colorectal Cancer; Anal Canal Cancer; Gastrointestinal Neuroendocrine Tumors. Primary outcome: Local Progression Free Survival. Colorectal eligibility wording from the registry: "* Histology of the primary tumor: colorectal adenocarcinoma, carcinoma of the anal canal or gastrointestinal neuroendocrine tumors". Sites: Brazil. No results are recorded here; the registry entry is the source.